Secondary cytoreduction for relapsed ovarian cancer reply

HFCAS OpenIR

	Secondary cytoreduction for relapsed ovarian cancer reply
	Chen, Yulian 1; Shi, Tingyan 1; Liu, Jihong 2; Zhu, Jianqing 3; Zang, Rongyu 1
	2021-06-01
发表期刊	LANCET ONCOLOGY
ISSN	1470-2045
通讯作者	Zang, Rongyu(zang.rongyu@zs-hospital.sh.cn)
收录类别	SCI
语种	英语
WOS研究方向	Oncology
WOS类目	Oncology
WOS记录号	WOS:000657432100016
出版者	ELSEVIER SCIENCE INC
引用统计
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/123942
专题	中国科学院合肥物质科学研究院
通讯作者	Zang, Rongyu
作者单位	1.Fudan Univ, Zhongshan Hosp, Dept Gynaecol Oncol, Ovarian Canc Program, Shanghai 200032, Peoples R China 2.Sun Yat Sen Univ, Dept Gynaecol Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China 3.Univ Chinese Acad Sci, Zhejiang Canc Hosp, Dept Gynaecol Oncol, Canc Hosp, Hangzhou, Peoples R China
推荐引用方式 GB/T 7714	Chen, Yulian,Shi, Tingyan,Liu, Jihong,et al. Secondary cytoreduction for relapsed ovarian cancer reply[J]. LANCET ONCOLOGY,2021,22.
APA	Chen, Yulian,Shi, Tingyan,Liu, Jihong,Zhu, Jianqing,&Zang, Rongyu.(2021).Secondary cytoreduction for relapsed ovarian cancer reply.LANCET ONCOLOGY,22.
MLA	Chen, Yulian,et al."Secondary cytoreduction for relapsed ovarian cancer reply".LANCET ONCOLOGY 22(2021).